Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.95 |
| ▸ | TFPI2 | P48307 | 2/20 | 0.95 |
| ▸ | NPY4R | P50391 | 2/20 | 0.95 |
| ▸ | PPP5C | P53041 | 2/20 | 0.95 |
| ▸ | PPM1A | P35813 | 1/20 | 0.95 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.95 |
| ▸ | PPP2R2A | P63151 | 1/20 | 0.95 |
| ▸ | PPP2R5A | Q15172 | 1/20 | 0.95 |
| ▸ | SLCO1B3 | Q9NPD5 | 3/20 | 0.93 |
| ▸ | SLCO1B1 | Q9Y6L6 | 3/20 | 0.93 |
| ▸ | PPM1B | O75688 | 1/20 | 0.81 |
| ▸ | MC4R | P32245 | 1/20 | 0.35 |
| ▸ | MC3R | P41968 | 1/20 | 0.35 |
| ▸ | KLK7 | P49862 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29711569 | 1.00 | PTPN1 (0.95) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL29350648 | 1.00 | PTPN1 (0.95) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL29350595 | 1.00 | PTPN1 (0.95) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL31005304 | 1.00 | PTPN1 (0.95) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL30788332 | 0.98 | SLCO1B3 (0.96) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL38650007 | 0.98 | SLCO1B3 (0.96) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL30788333 | 0.98 | SLCO1B3 (0.96) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| Microcystin-Lr SCHEMBL29349513 | 0.97 | PTPN1 (1.00) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL30859111 | 0.97 | PTPN1 (0.91) | PTPN1TFPI2NPY4RPPP5CPPM1A | |
| SCHEMBL29897131 | 0.97 | PTPN1 (1.00) | PTPN1TFPI2NPY4RPPP5CPPM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103480-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | SANOFI SA (FR) | 2026-04-16 | — | — | US | disclosed |
| US-20240425862-A1 | SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET | NITTO DENKO CORP (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240376137-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | SANOFI SA (FR) | 2024-11-14 | — | — | US | disclosed |
| US-11926831-B2 | SiRNA structures for high activity and reduced off target | NITTO DENKO CORPORATION (JP) | 2024-03-12 | — | — | US | disclosed |
| US-11897911-B2 | Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same | SANOFI (FR) | 2024-02-13 | — | — | US | disclosed |
| US-20220267779-A1 | SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET | NITTO DENKO CORPORATION (JP) | 2022-08-25 | — | — | US | disclosed |
| US-11390871-B2 | SiRNA structures for high activity and reduced off target | NITTO DENKO CORPORATION (JP) | 2022-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897911-B2 | Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same | RNMT, RRM2B, RRM2 | PTPN1 3591/4885TFPI2 3382/4885NPY4R 4753/4885 |
| US-20260103480-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | NSUN2, NSUN3, SNRPA | PTPN1 3251/4885TFPI2 4365/4885NPY4R 4270/4885 |
| US-20240376137-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | RNMT, NSUN2, ADAR | PTPN1 3501/4885TFPI2 4170/4885NPY4R 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.